Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
2009 Update for Home Care - The Joint Commission and Other Regulatory Issues
Track: Educational Sessions (CE)
Program Code: 236-L03
Date: Tuesday, December 8, 2009
Time: 8:00 AM to 11:00 AM EST
Location: 2204 - Titian
MEETING PLANNING ASSOCIATE:   Click the plus sign to see more detailed information about each speaker.
 Donald Filibeck, PharmD, MBA, National Director, Pharmacy Services, Critical Care Systems
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Donald Filibeck, PharmD, MBA, National Director, Pharmacy Services, Critical Care Systems
 Douglas Lang, RPh, Sr. Director Specialty Pharmacy Practice, Express Scripts
 Sandy Matiko-DeSanzo, CPhT, Manager, Payor Audits, Accredo Health Group, Inc.
 Darryl Rich, PharmD, MBA, Surveyor, The Joint Commission
Description
Planned in cooperation with the ASHP Section of Home, Ambulatory, and Chronic Care Practitioners
ACPE Activity #204-000-09-236-L03P
3.0 Contact Hours / Knowledge-based
Educational Content: General Interest
Moderator: Donald Filibeck, PharmD, MBA,
National Director, Pharmacy Services, Critical Care Systems, Nashua, NH; and Field Representative, The Joint Commission, Oakbrook Terrace, IL

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 9:05 a.m.
The Joint Commission Home Care Update
Darryl Rich, PharmD, MBA, FASHP,
Surveyor, The Joint Commission, Oakbrook Terrace, IL

9:05 a.m. – 9:45 a.m.
Surviving a DEA / Board of Pharmacy Audit
Douglas R. Lang,RPh,
Senior Director Specialty Pharmacy Practice, Express Scripts, Saint Louis, MO

9:45 a.m. – 10:25 a.m.
Surviving a Payor Audit
Sandy Matiko, CPhT,
Compliance Auditor, Accredo Health Group, Inc., Ellwood City, PA

10:25 a.m. – 10:50 a.m.
Surviving an FDA Audit
Donald Filibeck


10:50 a.m. – 11:00 a.m.
Questions, Answers, and Discussion


Learning Objectives:

LEARNER OUTCOMES:
  • Describe challenging standards and compliance issues associated with The Joint Commission standards for 2009.
  • Describe some of the anticipated changes in standards and/or the survey process for 2010.
  • Describe the process for dealing with a DEA and/or state Board of Pharmacy inspection.
  • Describe the process for dealing with a payer audit.
  • Describe the process for dealing with an FDA audit regarding drug and/or product recalls.


Audio Synchronized to PowerPoint
(Code: 236-L03)
Attendee:Free
  
This session is a part of:
Handout Online
View